KiwiDiab
KiwiDiab is a New Zealand-based national network established in 2019 to benchmark clinical data for children and adolescents with diabetes, covering over 95% of pediatric diabetes services. It aims to improve care, equity, and outcomes by analyzing data on Type 1 Diabetes (T1DM), including technology use (such as CGM and insulin pumps) and HbA1c levels. KiwiDiab meets annually on the afternoon preceding the NZPES Winter Meeting.
Purpose: To create a national dataset, enable benchmarking across services, and support improvements in equity and quality of care for tamariki and rangatahi.
First National Report (2023): Highlighted variation in diabetes technology use and HbA1c outcomes across New Zealand.
Key Findings: Provided national data on the prevalence, incidence, and management of T1DM, and identified inequities in glycaemic outcomes, particularly affecting Māori children.
Collaboration: KiwiDiab is supported by the New Zealand Paediatric Endocrine Society and the Paediatric Society of New Zealand.
Contact us through admin@nzpaedendo.co.nz
